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ABSTRACT
A SELEX (systematic evolution of ligands by
exponential enrichment)-based approach was
developed to determine whether HIV-RT showed pre-
ference for particular primer-template sequences. A
70 nt duplex DNA was designed with 20 nt fixed flank-
ing sequences at the 30 and 50 ends and a randomized
30 nt internal sequence. The fixed sequence at the
50 end contained a BbsI site six bases removed from
the randomized region. BbsI cuts downstream of its
recognition site generating four base 50 overhangs
with recessed 30 termini. Cleavage produced a 50 nt
template and 46 nt primer with the 30 terminus within
the randomized region. HIV-RT was incubated with
this substrate and material that bound RT was iso-
lated by gel-shift. The recovered material was treated
toregeneratetheBbsIsite,amplifiedbyPCR,cleaved
with BbsI and selected with HIV-RT again. This was
repeated for12rounds.Material from round 12bound
approximately 10-fold more tightly than starting
material. All selected round 12 primer-templates
had similar sequence configuration with a 6–8 base
G run at the 30 primer terminus, similar to the HIV
polypurine tract. Further modifications indicate that
the Gs were necessary and sufficient for strong
binding.
INTRODUCTION
Using an approach developed in the 1990s called SELEX
(systematic evolution of ligands by exponential enrichment)
(1–3), single-stranded nucleic acids that bind to human
immunodeﬁciency virus reverse transcriptase (HIV-RT)
with high afﬁnity were identiﬁed (4–6). The SELEX method
is based on differential binding of nucleic acids to a substrate
protein. Initially a large random pool of RNAs is incubated
with a limiting amount of protein. Nucleic acids that bind with
higher afﬁnity will preferentially associate with the protein
and can be isolated by gel-shift or nitrocellulose ﬁlter binding.
The selected pool is expanded using PCR then RNA transcrip-
tion and the new pool is subjected to another round of protein
binding. After several rounds nucleic acids with high afﬁnity
for the protein, also referred to as aptamers, can be isolated. In
the case of HIV-RT, these RNA aptamers were usually
pseudoknot-type structures (7). RNA psuedoknot aptamers
have been shown to interfere with primer-template binding
and are potent inhibitors of reverse transcription (8,9).
Single-stranded DNA aptamers with similar properties have
also been selected (10). For both RNA and DNA, the main
factor underlying tight binding to RT was the folded structure
rather than the sequence of the nucleic acids. This method has
since been used to isolate aptamers that can bind several dif-
ferent proteins, including several therapeutic targets [reviewed
in (11,12)]. Many of these aptamers are currently being devel-
oped as potential treatments for diseases.
The natural substrate for RT and most other polymerases is
duplex nucleic acid with a recessed 30 terminus (classical
primer-template conﬁguration). It is well established that
RT binds DNA primers on an RNA template more tightly
than on DNA templates; however, it is not known whether
strong sequence preferences exist. Tight binding sequences
could potentially be used to help design aptamers and aid
in understanding how RT recognizes and binds to substrates.
To determine whether tight binding DNA–DNA primer-
template sequences could be isolated, we used a novel
SELEX-based approach. Primer-template sequence that
bound 10-fold tighter than random sequences were selected.
All the recovered sequences had the same basic sequence
motifcharacterizedby a run of several G residues at the primer
30 terminus. In such, they mimicked the sequence of the poly-
purine tract (ppt) RNA primer used by HIV to initiate plus
strand DNA synthesis.
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Materials
Wild-type HIV-RT was from Worthington Biochemical
Corporation. TY-3 RT was a kind gift from Dr Stuart Le
Grice (HIV Drug Resistance Program, National Cancer Insti-
tute). Drug resistant HIV-RTs (D67N/K70R/T215F/K219Q
and K65R) were a kind gift from Dr Michael Parniak,
(University of Pittsburg). MuLV-RT was from United States
Biochemical. Taq polymerase was from Eppendorf. Restric-
tion enzymes, Klenow polymerase, and Pfu polymerase and
T4 polynucleotide kinase were from New England Biolabs.
Calf intestinal phosphatase and dNTPs were from Roche.
Rapid DNA ligation kit was from Promega. Competent
GC5 Escherichia coli cells were from Gene Choice. Miniprep
DNA preparation kit was form Qiagen. Radiolabeled com-
pounds were obtained from Amersham. Sephadex G-25
spin columns were from Amika Corp. All oliognucleotides
were from Integrated DNA Technologies. All other chemicals
were from Sigma or Fisher Scientiﬁc.
Methods
Production of substrate for initial round of selection. About
2500 pm of template 50-GCATGAATTCCCGAAGACGC
(N)30TCTAGAGTCGACCTGCAGGC-30 (N-any nucleotide)
was hybridized to  3000 pm of primer 50-GCCTGCAGGTC-
GACTCTAGA-30 that was 50 end-labeled with P-32 using T4
polynucleotide kinase and the manufacturer’s protocol.
Hybridization was performed in 50 mM Tris–HCl
(pH ¼ 8), 1 mM DTT and 80 mM KCl in a volume of
100 ml. The mixture was heated to 80 C then slow cooled
to room temperature. The material was divided into ﬁve
tubes and the primer in each was extended with 15 U of
Klenow polymerase using the following conditions: 50 mM
Tris–HCl (pH ¼ 8), 1 mM DTT, 25 mM KCl, 6 mM MgCl2
and 500 mM dNTPs. Reactions were for 2–3 h at 37 C. The
material was then combined, extracted with phenol:chlorofor-
m:isoamyl alcohol (25:24:1 v:v:v) and precipitated with 2 vol
of ethanol and 1/10th vol of 3 M Na acetate (pH ¼ 7). The
recovered material was divided into four reaction tubes and
digested with BbsI(50 U) in the appropriate bufferin a volume
of 150 ml overnight at 37 C. Material was run on a 13% native
polyacrylamide gel along with a small amount of uncut start-
ing material. About 1/2 of the material was digested to the
appropriate size as judged by UV shadowing. Digested mate-
rial was recovered by eluting from crushed gel slices overnight
in buffer containing 50 mM Tris–HCl (pH ¼ 8), 1 mM DTT,
80 mM KCl and 0.1 mM EDTA (pH ¼ 8) as described pre-
viously (13). Spectrophotometric analysis indicated that
 600 pm was recovered.
Selection of material with HIV-RT using gel-shift and
subsequent processing. In the initial round,  500 pm of sub-
strate from above was incubated with 20 pm of HIV-RT in a
buffer containing 50 mM Tris–HCl (pH ¼ 8), 80 mM KCl,
6 mM MgCl2, 1 mM DTT and 0.1 mM EDTA (pH ¼ 8).
Incubation was for 1 h at room temperature in a volume of
100 ml. For rounds 11 and 12 the KCl concentration was
increased to 150 mM. Material was then run on a 6% native
1.5 mm polyacrylamide gel at 125 V as described previously
(13). A control reaction containing 25 pm of material without
RT was also run. Shifted material was excised and eluted as
described above. Approximately 2–4 pm of material was
recovered as determined from speciﬁc activity. The recovered
material was extended with Klenow (2.5 U) to produce blunt
ends as described above except that 100 mM dNTPs were used,
the reaction volume was 50 ml, and the incubation time
was 15 min. The reaction was extracted and precipitated as
described above, then resuspended in 10 ml water. The recov-
ered material was ligated using a rapid ligation kit (Promega)
to 5–10-fold excess of the following two primers that were
hybridized together to form a duplex: 50-ATAGCATGAAT-
TCGCAGAAGACCC-30 and 50-GGGTCTTCTGCGAATT-
CATGC-30. Ligations were in a volume of 30 ml for round
one and 10 ml for all subsequent rounds using the manufac-
turer’s protocol except that reactions were for 2 h. Note that
hybridization of the primers will form a duplex with a blunt
end and an end with a 3 base 50 overhang. This was to help
direct the ligations (see Figure 1). Also, the protocol was
designed to direct ligations as shown in Figure 1 since the
only50 phosphorylatednucleic acidendinthereactions was on
the blunt ended randomized region of the substrate (‘N’ con-
taining region). A very small proportion of 50 ends would have
been phosphorylated at the other end of the selected material
due to 50 end labeling with P-32 (see above). After ligation,
PCRs were prepared in 400 ml total volume using the Taq
polymerase buffer provided by the manufacturer. Approxi-
mately 400 pm of each primer, (50-GCCTGCAGGTCGACT-
CTAGA-3 (P-32 end-labeled) and 50-GCATGAATTCGCA-
GAAGACCC-30), were added to reactions along with the
entire ligation mixture. The reactions were divided into four
tubes (100 ml each) and PCR was performed at 94 C (1 min),
50 C (1 min) and 72 C (1 min) for a total of 12–14 cycles
followed by an additional cycle of 5 min at 72 C. Material was
combined, extracted and ethanol-precipitated before digestion
with BbsI (50 U total in one 100 ml reaction as described
above). The digested material was run on a 13% native poly-
acrylamide gel and cleaved material was recovered as
described above and used in subsequent rounds of selection.
A total of 12 rounds of selection were performed. In each
round after round one,  1/20th equivalent of HIV-RT (mole:
mole) was incubated with the recovered substrate for the next
round of selection. Also, after round 2, 1/5th of the recovered
PCR material was saved as a source to regenerate the selected
material from that round or for use in Kd determinations
(see below).
Determination of equilibrium dissociation constants (Kd).
Selected material (1 nM) from various rounds of selection (see
Results) or other designed primer-templates (see Figure 3)
were end-labeled on the primer strand and mixed with various
amounts of HIV-RT (2.5, 5, 10, 15, 20, 40, 60, 80 and 100 nM
unless otherwise indicated) in 8 ml of buffer containing 50 mM
Tris–HCl (pH ¼ 8), 1 mM DTT, 80 mM KCl, 6 mM MgCl2
and 0.1 mg/ml BSA for 5 min at room temperature. Reactions
were initiated by the addition of 2 ml dNTPs (100 mM ﬁnal
in reactions) and heparin ‘trap’ (1 mg/ml ﬁnal in reactions)
in the same buffer as above. The trap was added to sequester
RT molecules not bound to the substrate and those that dis-
sociate. This limits extension to a single binding event
between the substrate and enzyme (14). Samples were incu-
bated for 2 min then stopped with an equal volume of 2· gel
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0.25% each bromphenol blue and xylene cyanol]. The reac-
tions were run on a 12% denaturing polyacrylamide gel as
described below, and dried gels were imaged using a BioRad
FX phosphoimager. The amount of bound enzyme at the vari-
ous concentrations of RT was determined from the level
of extended products. Controls for the effectiveness of the
trap and full extension of the substrate were also performed
as described in the various ﬁgures. Values for Kd were
determined by plotting the concentration of extended
product (nM) versus the concentration of HIV-RT and
ﬁtting the data by nonlinear least square ﬁt to the quadratic
equation:[ED] ¼ 0.5([E]t + [D]t + Kd)   0.5(([E]t + [D]t +
Kd)
2   4[ E]t[D]t)
1/2, where [E]t is the total enzyme
concentration and [D]t is the total primer-template
concentration (15).
Sequences analysis of products recovered from rounds 10
and 12. Products selected from rounds 10 and 12 were
sequences by cloning into vector pBSM13+. A portion of
the PCR products from each round were digested with HincII
and EcoRI. Sites for these enzymes are present in the 50 and 30
ﬂanking sequences, respectively (see Figure 1). The cleaved
products were isolated from a polyacrylamide gel as described
above and ligated into pBSM13+ that was previously cleaved
with the same restriction enzymes, and then dephosphorylated
with calf intestinal phosphatase. Ligation was performed using
the Rapid ligation kit as described above. Ligated material was
transformed into competent E.coli GC5 cells and DNA for
sequencing was prepared from bacterial colonies using a mini-
prep kit.
Dissociation rate constant (koff) determinations. Substrate (5
nMﬁnal concentration) and HIV-RT(15nM forsubstrate 12-1
and 100 nM for substrate 1-1) were mixed in 64 ml of buffer
containing 50 mM Tris–HCl (pH ¼ 8), 1 mM DTT, 80 mM
KCl, 6 mM MgCl2 and 0.1 mg/ml BSA and incubated for 3 min
at 37 C. Fifteen ml of trap solution in the same buffer with
heparin (1 mg/ml ﬁnal concentration) was added at time ‘0’.
Aliquots of 5.25 ml were removed at 10 s, 20 s, 40 s, 1 min,
2 min, 4 min, 8 min, 12 min and 16 min and added to a tube
containing 1 ml of dNTP (100 mM ﬁnal concentration) solution
in the same buffer. Incubations were continued for 2 min then
stopped with 2· loading buffer and subjected to electrophor-
esis on 12% polyacrylamide denaturing gels as described
below. A time ‘0’ sample was prepared by adding 4.25 ml
of the enzyme template mix to a tube with 1 ml each of
trap and dNTP mix. Off-rates were determined by plotting
the amount of extended product (determined using a phospho-
imager) versus time. A nonlinear least-squares ﬁt of the data to
an equation for single-exponential decay [f(x) ¼ ae
 bx, where
a is the y intercept at time 0 and b is the dissociation rate] was
used to graph the data using Sigma Plot (Jandel Corp).
Preparation of ddG terminated 12-1 loop-back substrate.
Fifty pm of 12-1 loop-back DNA (see Figure 5A) that was
labeled at the 50 end with P-32 at very low speciﬁc activity was
incubated with 5 U of Klenow polymerase in 50 ml of buffer
Figure 1. SELEX approach used to select tight bindingsequences. The diagram illustrates the basic approachused to isolate primer-template sequences that bound
HIV-RTwithhighaffinity.Thedouble-strandedDNAstartingmaterialcontaineda30ntrandomregionflankedbytwo20ntfixedsequences.TheBbsIcleavagesite
in the 50 fixed sequences was used to generate substrates with recessed 30 termini in the random region. These substrates (500 pm in the first round) were incubated
withalimitingamountofHIV-RTandboundmaterialwasisolatedbygel-shift.Therecoveredmaterialwasprocessedtoessentiallyregeneratethestartingmaterial
configuration. PCR was then used to amplify the selected material which was cleaved with BbsI and recovered by gel electrophoresis. This recovered material was
thensubjectedtoanotherroundofselectionforatotalof12rounds.*,InroundssubsequenttothefirstenoughRTtobind 1/20thofthetotalrecoveredmaterialwas
added. See Methods for details.
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KCl, 6 mM MgCl2 and 25 mM ddGTP for 30 min at 37 C. The
material was extracted and precipitated then run through a
sephadex spin column to remove any remaining ddGTP.
Recovered material co-migrated with 12-1 loop-back DNA
and was not extendable by HIV-RT in the presence of
dNTPs indicated that it was 30 terminated with ddG.
Competition binding assay. Reactions contained 10 nM (ﬁnal
concentration) 50 P-32 end-labeled 12-1 loop-back substrate
(see Figure 5) and 2 nM (ﬁnal concentration) HIV-RT in 8 ml
of buffer containing 50 mM Tris–HCl (pH ¼ 8), 1 mM DTT,
80 mM KCl, 6 mM MgCl2 and 0.1 mg/ml BSA. Various
amounts (0, 5, 10, 20, 30, 40, 60, 80 or 100 nM) of cold
competitor were also included in the reactions. Samples
were incubated at room temperature for 1 h. Reactions
were initiated by the addition of 2 ml dNTPs (100 mM ﬁnal
in reactions) and heparin ‘trap’ (1 mg/ml ﬁnal in reactions) in
the same buffer as above. After 2 min reactions were termi-
nated with 10 mlo f2 · loading buffer and subjected to elec-
trophoresis on 12% polyacrylamide denaturing gels as
described below. The amount of extended product was deter-
mined with a BioRad FX phosphoimager. A graph of relative
extension (the sample with no competitor added was assigned
a value of 1 and all other samples were relative to this) versus
amount of competitor was constructed.
Gel electrophoresis. Six or 13% native polyacrylamide (29:1
w:w acrylamide:bisacrylamide) or 12% denaturing polyacry-
lamide (19:1 w:w acrylamide:bisacrylamide, 7 M urea) gels
were prepared and subjected to electrophoresis using TBE
buffer as described previously (13).
RESULTS
Approach used to select tight binding sequences
The basic approach used for sequence selection is illustrated in
Figure 1 and described under Methods. The 30 nt length in the
randomized region was chosen based on the  30 nt footprint
of HIV-RT on primer-templates (16,17). Therefore, contacts
along the entire enzyme could be probed. With a 30 nt region
and 500 pm of starting material, this calculates to about 1 in
every 3800 possible sequences being represented. Despite this
small proportion, most ‘sequence motifs’ are likely to be pre-
sent unless they are very long. For example, all possible 20 nt
runs would be present more than 200 times each. Typically
enough RT to bind about 1/20th of the total recovered sub-
strate was used in each round (see Methods). With 12 rounds
of section this would in theory be enough to selected single
molecules from the starting material. The choice to stop the
selection after 12 rounds was determined based on the Kd
values for the various pools. Values were (in nM, average
of three experiments ± SD) 82 ± 14, 52 ± 15, 10 ± 3 and
12 ± 2, for the starting pool and rounds 6, 10 and 12, respec-
tively. Since rounds 10 and 12 had similar values, it was
assumed that no further gain in binding afﬁnity would be
made by additional rounds. Also, rounds 11 and 12 were per-
formed using 150 mM KCl in the selection as compared with
80 mM for the ﬁrst 10 rounds. The fact that no further decrease
in Kd occurred despite the more stringent conditions further
indicated that maximal binding was reached.
Tight binding substrates all contain a run of
6–8 G residues at the primer 30 end
Material from the round 10 and 12 selections was recovered,
cloned, and sequences as described in Methods. Shown in
Figure 2 are sequences from 18 clones from round 12 and
7 from round 10. Only the sequence of the primer strand in
the random region is shown. All the sequences contained the
additional 20 nt at the 50 end derived from the PCR primer (see
Figure 1). In theory, the primer strand should be 30 nt in the
random region. The recovered products were 29–31 nt with
some having one base additions or deletions in the random
region, presumably resulting from PCR errors. Although the
round 10 and 12 sequences were clearly related, only one was
recovered in both pools (round 12 #18 and round 10 #1). None
of the sequences from round 12 was identical;however, 17 had
a 6–8 nt run of Gs at what would be the primer terminus after
BbsI cleavage (underlined), while the other one (number 16)
had a 30 terminal C residue preceded by a run of 6 Gs.
There were also other common features including most
sequences having a 2–3 nt A run preceding the Gs. The As
were typically preceded by a G-C rich region. Since these
substrates were derived by selection and PCR, common fea-
tures contributing to tight binding, as well as other non-
relevant common features might be expected. This was
explored below.
Figure 2. Sequence of the material recovered from rounds 10 and 12.
Sequences of the round 10 and 12 material in the 30 nt random region of
the primer strand are shown. All sequences are aligned at the 30 end and the
firstsixbasesoftheprimerstrandthatwouldbepresentaftercleavagewithBbsI
areunderlined.Manyrecoveredsequencesweretruncatedby1ntandlostbases
( )aredenotedatthe50 end.Twosequenceshada1ntaddition(showninbold
atthe50 end)resultingina31baserandomregion.‘N’denotesanucleotidethat
was not clearly identified during sequencing.
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In order to determine what motif(s) of the recovered substrates
was important for tight binding several changes to the
sequences were made. The sequence labeled number 1 in
Figure 2 was used as a model sequence because it retained
the 30 nt length in the random region and represented a reason-
able ‘consensus’ of all the recovered sequences (determined
using BioEdit). This substrate is labeled 12-1 in Figure 3. Two
random sequences recovered from the starting material were
also used in these experiments (labeled 1-1 and 1-2). Because
of the strong related nature of the round 12 sequences it was
not deemed necessary to analyze several sequences.
The Kd values for each substrate in Figure 3A are listed in
parentheses near the substrate. An autoradiogram from a typi-
cal Kd determination experiment with 1-1 and 12-1 is shown in
Figure 3B and graphed in Figure 3C. The measured value for
12-1 was at least an order of magnitude lower than the values
for 1-1 and 1-2. To determine why, several chimeric substrates
were tested that included sequences derived from both 12-1
and 1-1 as well as other changes. In the ‘2 Gs’ substrate the run
of 7 G’s in 12-1 was reduced to two at the 30 terminus with the
other nucleotides of the run replaced by mostly 1-1 nt. This
substrate bound comparably with 1-1 indicating that a run
of Gs greater than two is required for tight binding. Substrates
‘12 Gs’ and ‘26 Gs’ increased the length of the G run in 12-1
to 12 and 26 nt, respectively. The latter represents a complete
G-C primer-template sequence in the random region of the
substrate.Bothsubstratesboundatleastastightlyas12-1,with
26 Gs showing slightly tighter binding. These results indicate
that the longer runs of Gs do not prevent tight binding and
there may even be slightly tighter binding with very long runs.
Two additional substrates were tested. In one (7 Gs template)
the 7 Gs in the primer strand were switched into the template
and the C’s in the template switched to the primer. This sub-
strate lost the ability to bind tightly indicating that the G
residues must be in the primer strand for tight binding. Finally,
a substrate that retained the 7 Gs from 12-1 but had all other
nucleotides in the random region replaced by 1-1 nt was tested
(7 Gs only). This substrate retained tight binding, although
there was some increase in the average Kd value (from 5 ± 1
with 12-1 to 12 ± 7 with 7 Gs only). In this case, the increase
was not great enough to be signiﬁcant.
To further verify the tight binding observed with 12-1, an
off-rate determination was performed using 1-1 and 12-1
(Figure 4). An autoradiogram is shown in Figure 4A and
graphed in Figure 4B. The koff values determined in this
experiment were 0.0009/s and 0.0093/s for 12-1 and 1-1,
respectively. This was consistent with the 10-fold lower Kd
observed for 12-1. The result also indicates that the tighter
binding was caused by a slower dissociation rate from the
substrate rather than a change in the association rate. This
experiment was repeated with similar results.
The afﬁnity of MuLV-RT and TY-3 RT for 1-1 and 12-1
was also measured. MuLV-RT showed  3-fold tighter bind-
ing to 12-1 compared with 1-1 while no difference was
observed with TY-3 RT. Two drug resistant forms of HIV-
RT, and D67N/K70R/T215F/K219Q and K65R (18,19), both
showed a strong preference for 12-1 similar to wild-type
RT (data not shown).
Overall, the results show that a run of several G residues at
the 30 primer terminus on a DNA–DNA primer-template leads
to tight binding by RT. The tight binding results from slow
dissociation of RT from the substrate and the Gs must be in the
primer strand.
Aloop-backDNAbutnotRNAsubstratedesignedbased
on 12-1 binds very tightly to RT and binding is not
inhibited by a terminal dideoxy G residue
The above results demonstrated that a run of Gs, similar to that
observed on the HIV ppt RNA, was responsible for the tight
binding of the selected primer-template sequences. To deter-
mine whether an RNA version of the high afﬁnity substrate
could also bind tightly, a competition assay was developed.
First, single-stranded 60 nt versions of 1-1 and 12-1 that
formed a loop-back primer-templates were made (Figure 5).
The loop-back substrates retained only the sequences in the
random region plus an additional four A residues that formed
the loop. Values for Kds of 26 ± 12 and 2.2 ± 0.4 nM were
measured for the 1-1 and 12-1 loop-backs, respectively. In
each case, this was about 1/2 the value of the original substrate
indicating slightlytighterbinding tothe loop-backs.There was
an  10-fold tighter binding for the 12-1 loop-back substrate
compared with 1-1 loop-back, consistent with what was
observed with the two stranded substrates.
Other loop-back substrates were also tested using a com-
petition assay. In this assay, increasing amounts of cold com-
petitor were added to a reaction containing a ﬁxed amount of
the radiolabeled 12-1 loop-back substrate. This mixture was
incubated with a ﬁxed amount of RT for 1 h, followed by
addition of dNTPs and heparin trap as described in Methods.
The presence of competitor reduces the amount of RT that
bound to and extended the labeled 12-1 loop-back depending
on the amount of competitor and its afﬁnity for RT. The
competitors used were the 1-1 and 12-1 loop-back substrates,
an RNA version of the 12-1 loop-back and a version of 12-1
loop-back in which the 30 terminal G residue was a dideoxy
nucleotide. The RNA substrate would have more potential as
an RT inhibitor because it can be expressed in cells after
transfection or infection with virus-based vectors as has
been carried out with other RT aptamer inhibitors (4). An
autoradiogram from a typical competition assay is shown in
Figure 6A while a graph is presented in Figure 6B. As
expected, cold 12-1 loop-back was able to effectively compete
against radiolabeled 12-1 loop-back, leading to a decrease in
the amount of the latter that was extended in the assay. The
dideoxy version of 12-1 loop-back was also an effective com-
petitor, indicating that the presence of a non-extendable G
residue at the 30 terminal position does not signiﬁcantly affect
the afﬁnity of RT for the substrates. In contrast, 1-1 loop-back
and the RNA version of 12-1 loop-back (data not shown)
showed no substantial inhibition of extension even when pre-
sent at 10-fold greater concentration than 12-1 loop-back.
DISCUSSION
In this article, we show for the ﬁrst time that speciﬁc primer-
template sequences bind HIV-RT with greater afﬁnity than
random sequences. Tight binding in the recovered sequences
resulted from a run of 6–8 G residues at the 30 primer terminus.
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Figure3.(A–C).SubstratesmeasuredforbindingaffinitytoHIV-RT.(A)Shownarediagramsof8differentsubstratestestedforaffinitytoHIV-RT.The20basepair
fixedregionisdenotedbydashes(-----)andwasidenticalforallsubstrates(seeFigure1).Sequencescorrespondingtotherandomregionfromthefirstcloneshown
inFigure2(round12#1)areshowninboldinsubstrate12-1(boldletters).Substrates1-1(underlinednt)and1-2wererandomlyrecoveredfromthestartingmaterial
to serve as controls. Other substrates were as shown. When bases derived from 12-1 or 1-1 were used to construct chimeric substrates they are denoted in bold or
underlinedletters,respectively.ThenameandKdvalueforbindingtoHIV-RT(inparentheses)isshowntotherightofeachsubstrate.Valuesarefromanaverageofat
leastthreeexperiments ± SD.(B)Anautoradiogramfromatypicalexperimentusingsubstrates1-1and12-1isshown.Thesubstrate(1nM)was50 P-32end-labeled
on the primer strand and mixed with various amounts of HIV-RT as described in Methods. Reactions were initiated by the addition of dNTPs and heparin ‘trap’ to
sequester RT molecules not bound to the substrate and those that dissociate. This limits extension to a single binding event between the substrate and enzyme. The
concentrationsofRTusedwerefromlefttoright:2.5,5,10,15,20,40,60,80and100nM.Extendedandnon-extendedprimerpositionsareindicated.Theamountof
boundenzymeatthevariousconcentrationsofRTwasdeterminedfromthelevelofextendedproductsusingaphosphoimager.LaneA,noenzymeadded;laneB,full
extensionofsubstrateintheabsenceoftrapwith40nMRT;laneC,RT(40nM)wasaddedtoareactioncontainingtrap,dNTPsandsubstrateandincubatedfor3min
(trap control).(C) Exampleof a graph used to determine the equilibriumdissociation constant(Kd). Aplot of [Boundsubstrate]versus [HIV-RT]foran experiment
with1-1and12-1isshown.TheconcentrationsofRTusedintheassaysdependedonRT’saffinityfortheparticularsubstrateandwerechosentospantherangeofthe
approximateKdvalue.For12-1RTconcentrationswere1.3,2.5,5,7.5and10nMandfor1-1,20,40,60,80and100nMwereused.Theplottedvalueswerefittedtoan
equation for determining the Kd value (see Methods). The determined values for this particular experiment are listed on the graph.
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than 6–8 also bound tightly (see Figure 3). However, a mini-
mum length was required as a substrate with a two base run
bound comparable to random pool sequences. Including a
single dideoxy G residue at the 30 primer terminus did not
signiﬁcantly affect the afﬁnity of RT for the substrate
(Figure 6).
The recovered sequences closely resembled the 30 end of the
HIV ppt RNA which has a 6 base G run. Results suggest that
HIV-RT uses the ppt to prime second strand synthesis not only
because it is resistant to cleavage by RNase H, but also due to
its unique structure which allows RT to bind tightly and in the
proper orientation for nucleotide addition (20). With this in
mind, it may actually be the structure rather than sequence of
the primer-templates selected here that allowed them to bind
so well. Sequences rich in G + C and containing G-tracts
(stretched of G-C base pairs) are known to favor B-form to
A-form transitions in solution (21–24) and crystal structures
(25–27). Although HIV-RT can perform nucleotide catalysis
on RNA–DNA (normally A0-form), DNA–DNA (normally B-
form) and even RNA–RNA hybrids (normally A-form) in the
case of tRNA extension, crystallographic analysis of several
polymerases including RT indicates that the hybrid region
immediately adjacent to the polymerase active site is in an
A0-form even for DNA–DNA substrates (28–31). The A0-form
at the active site and that of RNA–DNA hybrids are not ident-
ical (32). It is also known that RT binds RNA–DNA hybrids
much tighter than DNA–DNA (33–35). The propensity of G-C
rich DNA hybrids to transition to the A-form suggests that it
may require less distortion for these hybrids to conform to an
A0-form that is catalytically competent. This could in turn lead
to tighter binding.
Another possible explanation for the tight binding of the
selected material is that the run of G residues could intro-
duce a bend that helps the substrate ﬁt into RT’s active
site, as is proposed to occur with the ppt (20). Crystal struc-
tures show that when bound to RT, an  45  bend is observed
in the primer-template (31). Although A-tracts are more typi-
cally associated with DNA bending, runs of G residues have
also been shown to induce curvature to a lesser extent (36,37).
This could help RT bind more tightly if the induced curvature
favored a better ﬁt to the active site. The curvature induced by
A-tracts seems not to induce tight binding to RT as no tight
binding primer-templates with long A runs were selected in
these experiments. It is interesting in this regard that A- and G-
tracts tend to induce curvature in the opposite directions with
the former compressing the DNA minor grove and the latter
the major (37).
A
B
Figure 4. (A and B). Off-rate determination for substrates 12-1 and 1-1. (A) Substrates 1-1 or 12-1 were preincubated with 100 or 15 nM HIV-RT, respectively. A
mixturecontainingheparintrapwasaddedtothereactionsandaliquotswereremovedat10s,20s,40s,1min,2min,4min,8min,12minand16min,mixedwitha
solution containing dNTPs and incubated for 3 min. Extended products represent the amount of RT remaining bound to the substrate at the various time points. For
time 0 (reactionsafter lane D for each substrate), a mixturecontaining dNTPsand heparin trap was mixed with the RT-substratepreincubation solution.Lane A, no
enzyme;lanesB–D,RT(100or15nMfor1-1or12-1,respectively)wasaddedtoareactionscontainingheparintrap,dNTPs,andsubstrateandincubatedfor1(A),8
(B)or16(C)min(trapcontrols).(B)Plotofrelativeextensionversustimefortheexperimentshownin(A).Theamountofextendedsubstrateforthetime0pointwas
assignedavalueof1andallotherpointsarerelativetothis.Off-rates(koff)weredeterminedbyfittingthedatatoanequationforexponentialdecay(seeMethods)and
are listed on the graph for the two substrates. This experiment was repeated with similar results.
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strate did not bind RT tightly as judged from the competition
assay (data not shown). Two possible reasons for this are that
the template region in this substrate is also RNA and that RT
simply binds RNA primers relatively poorly. RT recognizes
the ppt primer in the context of a DNA template and this may
be pivotal for tight binding. Indeed, although our discussion
has focused on the G run in the primer strand, the comple-
mentary deoxycytosine run in the template could be as impor-
tant with respect to the substrate conforming for tight binding.
As for binding to RNA primers, RT binds to the 50 end of most
RNAs recessed on a longer DNA (primer conﬁguration) and
degrades rather than extending them (38,39). The ppt repre-
sents a special case where RT is directed to the 30 end for
extension. The RNA version of 12-1 loop-back did not have
the complete ppt sequence nor was the template region DNA.
The substrate could be extended by RT but extension was
inefﬁcient compared with the DNA substrate (data not
shown). Therefore, it was not clear that RT even bound pref-
erentially to the 30 terminus on this substrate. Also, DNA
versions of the ppt are actually more efﬁcient primers than
the ppt (40). This suggests that even an optimized RNA primer
does not function as well as DNA primers, although it is not
clear whether this results from lower afﬁnity for RT or inef-
ﬁcient nucleotide addition.
Reverse transcriptase from Moloney murine leukemia virus
(MuLV) showed a preference for binding 12-1 over 1-1 while
TY-3 RT did not. The latter ﬁnding showed that the G-rich
primer-templates do not bind all RTs tightly but show some
speciﬁcity. It is interesting that the ppt of MuLV closely
resembles HIV with a 6 nt G run near the 30 terminus,
while the TY-3 ppt has no such run. Again this suggests
that the run of Gs may induce a structure that allows RT to
bind tightly, but not all RTs have evolved to bind strongly to
this motif. It would be appealing to see if a SELEX with TY-3
pulled out a sequence closely resembling its ppt or if MuLV-
RT selected the same sequences as HIV-RT.
As was noted in the introduction, single-stranded DNA
molecules that bind HIV-RT with high afﬁnity have been
selected using SELEX techniques (10). The selected ligands
bound with afﬁnities similar to the tight binding primer-
templatesfoundhere.Amongtheselected ligandswereseveral
AB
Figure 5. (A and B). Kd determination for 12-1 and 1-1 loop-back substrates. (A) Schematic diagrams of 12-1 and 1-1 loop-back substrates are shown. The 60 nt
substratesarecomposedofonlyonestrandofDNAandwerederivedfromtheoriginal12-1and1-1substrates(seeFigure3)usingonlythenucleotidesintherandom
region and four additional A residues in the loop. (B) An autoradiogram from a typical experiment used to determine the Kd value for substrates 1-1 and 12-1 loop-
back.Theamountofenzymeusedineach reactionislistedabovethe individuallanes andwasdifferentforthe twosubstrates.SeeFigure3Bfora descriptionofthe
assay and markings. For 1-1 and 12-1 loop-back the Kd values were 26 ± 12 and 2.2 ± 0.4 nM (average of three experiments ± SD).
Nucleic Acids Research, 2006, Vol. 34, No. 1 137predicted to fold and form 30 recessed termini that contained a
run of G residues. Since the invariant region of these mole-
cules contained a run of 4 Gs at the 30 terminus, this is not
surprising. The authors concluded that the folded structure of
the ligands was most important to binding RT with high afﬁn-
ity rather than particular sequences. In light of what we show
here it would be interesting to see if the G run played a role in
the tight binding for some of the ligands. It was clearly not the
onlyimportantparameterasseveral tightbindingligands with-
out this motif were also selected.
Overall, these results demonstrate that the sequence of a
primer-template can play a role in determining how tightly it
binds to RT. With HIV-RT the difference can be an order of
magnitude or more. Whether this is a general phenomenon for
all polymerases or is unique to some reverse transcriptases is
not known. The resemblance of the sequences recovered here
to the HIV ppt suggests that tight binding may result from
evolutionary pressure to recognize a particular structure
induced by the sequence. If this were the case, other poly-
merases would probably not show such a striking range of
afﬁnities.
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